Morgan Stanley started coverage on shares of Waystar (NASDAQ:WAY – Free Report) in a research report report published on Monday morning, MarketBeat Ratings reports. The firm issued an equal weight rating and a $28.00 price objective on the stock.
Other equities analysts have also issued research reports about the company. BMO Capital Markets decreased their price target on Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, February 18th. Evercore set a $27.00 price target on shares of Waystar in a report on Wednesday, February 18th. Citigroup lowered their price target on Waystar from $46.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Truist Financial decreased their price objective on shares of Waystar from $51.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, February 18th. Finally, Raymond James Financial reiterated a “strong-buy” rating and set a $35.00 price target on shares of Waystar in a report on Thursday, March 5th. Three investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.58.
View Our Latest Stock Report on Waystar
Waystar Stock Down 0.3%
Waystar (NASDAQ:WAY – Get Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.03). The business had revenue of $303.54 million during the quarter, compared to analyst estimates of $294.72 million. Waystar had a return on equity of 6.86% and a net margin of 10.20%.The company’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.29 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Equities research analysts forecast that Waystar will post 0.39 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Waystar news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $30.08, for a total value of $1,209,968.00. Following the completion of the transaction, the insider owned 474,826 shares of the company’s stock, valued at $14,282,766.08. This represents a 7.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 4.10% of the stock is currently owned by company insiders.
Institutional Trading of Waystar
A number of institutional investors and hedge funds have recently modified their holdings of WAY. Salomon & Ludwin LLC bought a new position in Waystar in the third quarter worth $25,000. ANTIPODES PARTNERS Ltd increased its holdings in Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after buying an additional 449 shares during the period. First Horizon Corp acquired a new position in shares of Waystar in the 3rd quarter valued at $38,000. Smartleaf Asset Management LLC raised its stake in shares of Waystar by 6,005.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company’s stock valued at $38,000 after buying an additional 1,141 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Waystar by 3,219.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after acquiring an additional 1,352 shares during the period.
About Waystar
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Stories
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
